RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+13.86%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$1.87B
AUM Growth
+$1.87B
(+28%)
Cap. Flow
+$367M
Cap. Flow
% of AUM
19.6%
Top 10 Holdings %
Top 10 Hldgs %
60.38%
Holding
58
New
8
Increased
29
Reduced
10
Closed
6
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$98.8M |
| 2 |
Stoke Therapeutics
STOK
|
$92.6M |
| 3 |
Milestone Pharmaceuticals
MIST
|
$91M |
| 4 |
Sarepta Therapeutics
SRPT
|
$40.4M |
| 5 |
Illumina
ILMN
|
$30.2M |
Top Sells
| 1 |
LivaNova
LIVN
|
$42.3M |
| 2 |
SI-BONE Inc
SIBN
|
$23.9M |
| 3 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$20.4M |
| 4 |
Wave Life Sciences
WVE
|
$17M |
| 5 |
Arrowhead Research
ARWR
|
$10.8M |
Sector Composition
| 1 | Healthcare | 94.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Rocket Pharmaceuticals
RCKT
$354M
| $249M | 13.29% | 16,587,491 +550,005 | +3% | +$8.25M |
|
|
2
Alnylam Pharmaceuticals
ALNY
$58.5B
| $159M | 8.52% | 2,198,094 +1,362,221 | +163% | +$98.8M |
|
3
PTC Therapeutics
PTCT
$3.92B
| $141M | 7.54% | 3,137,361 +623,090 | +25% | +$28M |
|
|
DRNA
4
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $96.9M | 5.18% | 6,152,103 -70,933 | -1% | -$1.12M |
|
|
5
Stoke Therapeutics
STOK
$1.08B
| $92.6M | 4.94% | +3,355,466 | New | +$92.6M |
|
|
6
Sarepta Therapeutics
SRPT
$1.78B
| $91.8M | 4.9% | 604,236 +266,037 | +79% | +$40.4M |
|
|
7
Milestone Pharmaceuticals
MIST
$156M
| $91M | 4.86% | +3,521,856 | New | +$91M |
|
8
Adverum Biotechnologies
ADVM
$64.6M
| $75.1M | 4.01% | 6,320,350 +63,510 | +1% | +$755K |
|
9
Bristol-Myers Squibb
BMY
$96B
| $70.8M | 3.78% | 1,561,918 +36,454 | +2% | +$1.65M |
|
|
AXNX
10
DELISTED
Axonics, Inc. Common Stock
AXNX
| $62.9M | 3.36% | 1,534,605 +10,575 | +0.7% | +$433K |
|
11
Masimo
MASI
$7.59B
| $55.4M | 2.96% | 372,258 +8,689 | +2% | +$1.29M |
|
12
Vericel Corp
VCEL
$1.83B
| $49.2M | 2.63% | 2,606,771 +118,849 | +5% | +$2.25M |
|
13
Establishment Labs
ESTA
$1.2B
| $41.4M | 2.21% | 1,883,180 +557,641 | +42% | +$12.3M |
|
14
Q32 Bio
QTTB
$20.9M
| $40.2M | 2.15% | 2,054,932 +318,213 | +18% | +$6.23M |
|
|
ACHN
15
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $37.2M | 1.98% | 13,864,383 +115,000 | +0.8% | +$308K |
|
|
MYOK
16
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $36.3M | 1.94% | 723,455 +16,885 | +2% | +$847K |
|
17
ProQR Therapeutics
PRQR
$237M
| $33.9M | 1.81% | 3,722,950 | – | – |
|
|
TBIO
18
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $30.8M | 1.65% | 2,439,250 +1,086,280 | +80% | +$13.7M |
|
|
AGEN
19
Agenus
AGEN
$133M
| $30.3M | 1.62% | 10,084,214 +201,001 | +2% | +$603K |
|
|
20
Illumina
ILMN
$15.8B
| $30.2M | 1.61% | +82,000 | New | +$30.2M |
|
|
21
Arrowhead Research
ARWR
$3.05B
| $29.7M | 1.59% | 1,120,346 -407,867 | -27% | -$10.8M |
|
|
MRTX
22
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $26.3M | 1.4% | 255,270 -56,823 | -18% | -$5.85M |
|
23
Standard BioTools
LAB
$481M
| $25.6M | 1.37% | 2,077,471 +146,537 | +8% | +$1.81M |
|
24
Apyx Medical
APYX
$75.3M
| $22.8M | 1.22% | 3,399,899 +275,000 | +9% | +$1.85M |
|
25
Axsome Therapeutics
AXSM
$6.05B
| $21.7M | 1.16% | 844,289 +248,654 | +42% | +$6.4M |
|